High-dose pharmaceutical-grade biotin in patients with demyelinating neuropathies: a phase 2b open label, uncontrolled, pilot study.
BMC Neurol
; 23(1): 389, 2023 Oct 30.
Article
in En
| MEDLINE
| ID: mdl-37899433
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Charcot-Marie-Tooth Disease
/
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Language:
En
Journal:
BMC Neurol
Year:
2023
Type:
Article
Affiliation country:
France